Literature DB >> 18268016

The nature of the stable blood clot procoagulant activities.

Thomas Orfeo1, Kathleen E Brummel-Ziedins, Matthew Gissel, Saulius Butenas, Kenneth G Mann.   

Abstract

The function of tissue factor (Tf)-initiated coagulation is hemorrhage control through the formation and maintenance of an impermeable platelet-fibrin barrier. The catalytic processes involved in the clot maintenance function are not well defined, although the rebleeding problems characteristic of individuals with hemophilias A and B suggest a link between specific defects in the Tf-initiated process and defects in the maintenance function. We have previously demonstrated, using a methodology of "flow replacement" (or resupply) of ongoing Tf-initiated reactions with fresh reactants, that procoagulant complexes are produced during Tf-initiated coagulation, which are capable of reinitiating coagulation without input from extrinsic factor Xase activity (Orfeo, T., Butenas, S., Brummel-Ziedins, K. E., and Mann, K. G. (2005) J. Biol. Chem. 280, 42887-42896). Here we used Tf-initiated reactions in normal and hemophilia blood or in their corresponding proteome mixtures as sources of procoagulant end products and then varied the resupplying material to determine the identity of the catalysts that drive the new cycle of thrombin formation. The central findings are as follows: 1) the prothrombinase complex (fVa-fXa-Ca(2+)-membrane) accumulated during the episode of Tf-initiated coagulation is the primary catalyst responsible for the observed pattern of prothrombin activation after resupply; 2) impairments in intrinsic factor Xase function, i.e. hemophilias A and B, result in an impaired capacity to mount a resupply response; and 3) in normal hemostasis the intrinsic factor Xase function contributes to the durability of the resupply response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268016      PMCID: PMC2442304          DOI: 10.1074/jbc.M707435200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  75 in total

1.  Blood clotting in minimally altered whole blood.

Authors:  M D Rand; J B Lock; C van't Veer; D P Gaffney; K G Mann
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

2.  Synthetic selective inhibitors of thrombin.

Authors:  S Okamoto; A Hijikata-Okunomiya
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

3.  The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.

Authors:  R Kumar; S Béguin; H C Hemker
Journal:  Thromb Haemost       Date:  1994-11       Impact factor: 5.249

4.  Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis.

Authors:  P J Fay; T L Beattie; L M Regan; L M O'Brien; R J Kaufman
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

5.  Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II.

Authors:  C van 't Veer; K G Mann
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

6.  Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases.

Authors:  S Butenas; C van 't Veer; K G Mann
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

7.  Tissue factor in plasma of patients with disseminated intravascular coagulation.

Authors:  H Takahashi; N Satoh; K Wada; E Takakuwa; Y Seki; A Shibata
Journal:  Am J Hematol       Date:  1994-08       Impact factor: 10.047

8.  A model for the tissue factor pathway to thrombin. I. An empirical study.

Authors:  J H Lawson; M Kalafatis; S Stram; K G Mann
Journal:  J Biol Chem       Date:  1994-09-16       Impact factor: 5.157

9.  Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins.

Authors:  P Bendayan; H Boccalon; D Dupouy; B Boneu
Journal:  Thromb Haemost       Date:  1994-05       Impact factor: 5.249

10.  The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.

Authors:  R Kumar; S Béguin; H C Hemker
Journal:  Thromb Haemost       Date:  1995-09       Impact factor: 5.249

View more
  19 in total

1.  Is there value in kinetic modeling of thrombin generation? Yes.

Authors:  K G Mann
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

2.  The impact of uncertainty in a blood coagulation model.

Authors:  Christopher M Danforth; Thomas Orfeo; Kenneth G Mann; Kathleen E Brummel-Ziedins; Stephen J Everse
Journal:  Math Med Biol       Date:  2009-05-18       Impact factor: 1.854

3.  Blood coagulation dynamics in haemostasis.

Authors:  K G Mann; T Orfeo; S Butenas; A Undas; K Brummel-Ziedins
Journal:  Hamostaseologie       Date:  2009-01       Impact factor: 1.778

4.  Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.

Authors:  M M Aleman; C Gardiner; P Harrison; A S Wolberg
Journal:  J Thromb Haemost       Date:  2011-11       Impact factor: 5.824

5.  Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.

Authors:  Laura M Haynes; Thomas Orfeo; Kenneth G Mann; Stephen J Everse; Kathleen E Brummel-Ziedins
Journal:  Biophys J       Date:  2017-04-25       Impact factor: 4.033

Review 6.  A Molecular Revolution in the Treatment of Hemophilia.

Authors:  John S S Butterfield; Kerry M Hege; Roland W Herzog; Radoslaw Kaczmarek
Journal:  Mol Ther       Date:  2019-11-13       Impact factor: 11.454

7.  Rivaroxaban delivery and reversal at a venous flow rate.

Authors:  Laura M Haynes; Thomas Orfeo; Kenneth G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-27       Impact factor: 8.311

Review 8.  Thrombin generation in hemorrhage control and vascular occlusion.

Authors:  Kenneth G Mann
Journal:  Circulation       Date:  2011-07-12       Impact factor: 29.690

9.  Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.

Authors:  Frauke Swieringa; Marijke J E Kuijpers; Moniek M E Lamers; Paola E J van der Meijden; Johan W M Heemskerk
Journal:  Haematologica       Date:  2015-03-13       Impact factor: 9.941

10.  The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization.

Authors:  Kathleen E Brummel-Ziedins; Matthew Gissel; Charles Francis; John Queenan; Kenneth G Mann
Journal:  Thromb Res       Date:  2009-03-17       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.